drugset / Trial / NCT03003195
The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the clinical efficacy of an investigational agent, P10s-PADRE, a peptide mimotope-based vaccine in subjects with metastatic cancer.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P10s-PADRE | Peptide | 1 ml | Subcutaneous |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | Subcutaneous |